| Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial A Garber, R Henry, R Ratner, PA Garcia-Hernandez, H Rodriguez-Pattzi, ... The Lancet 373 (9662), 473-481, 2009 | 1571 | 2009 |
| Teriparatide for acceleration of fracture repair in humans: a prospective, randomized, double‐blind study of 102 postmenopausal women with distal radial fractures P Aspenberg, HK Genant, T Johansson, AJ Nino, K See, K Krohn, ... Journal of Bone and Mineral Research 25 (2), 404-414, 2010 | 632 | 2010 |
| Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised … P Dandona, C Mathieu, M Phillip, L Hansen, SC Griffen, D Tschöpe, ... The lancet Diabetes & endocrinology 5 (11), 864-876, 2017 | 315 | 2017 |
| Effects of intravenous zoledronic acid once yearly on bone remodeling and bone structure RR Recker, PD Delmas, J Halse, IR Reid, S Boonen, ... Journal of Bone and Mineral Research 23 (1), 6-16, 2008 | 296 | 2008 |
| Effect of insulin glargine up-titration vs insulin degludec/liraglutide on glycated hemoglobin levels in patients with uncontrolled type 2 diabetes: the DUAL V randomized … I Lingvay, FP Manghi, P García-Hernández, P Norwood, L Lehmann, ... Jama 315 (9), 898-907, 2016 | 288 | 2016 |
| Effect of transdermal teriparatide administration on bone mineral density in postmenopausal women F Cosman, NE Lane, MA Bolognese, JR Zanchetta, PA Garcia-Hernandez, ... The Journal of Clinical Endocrinology & Metabolism 95 (1), 151-158, 2010 | 186 | 2010 |
| LEAD-3 (Mono) Study Group Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial A Garber, R Henry, R Ratner, PA Garcia-Hernandez, H Rodriguez-Pattzi, ... Lancet 373 (9662), 473-481, 2009 | 63 | 2009 |
| Effects of teriparatide compared with risedronate on recovery after pertrochanteric hip fracture: results of a randomized, active-controlled, double-blind clinical trial at 26 … P Aspenberg, J Malouf, U Tarantino, PA García-Hernández, C Corradini, ... JBJS 98 (22), 1868-1878, 2016 | 59 | 2016 |
| Limited risk of kidney stone formation during long-term calcium citrate supplementation in nonstone forming subjects K Sakhaee, S Baker, J Zerwekh, J Poindexter, PA Garcia-Hernandez, ... The Journal of urology 152 (2), 324-327, 1994 | 52 | 1994 |
| Effect of teriparatide or risedronate in elderly patients with a recent pertrochanteric hip fracture: final results of a 78‐week randomized clinical trial J Malouf‐Sierra, U Tarantino, PA García‐Hernández, C Corradini, ... Journal of Bone and Mineral Research 32 (5), 1040-1051, 2017 | 50 | 2017 |
| One‐year efficacy and safety of saxagliptin add‐on in patients receiving dapagliflozin and metformin S Matthaei, N Aggarwal, P Garcia‐Hernandez, N Iqbal, H Chen, ... Diabetes, Obesity and Metabolism 18 (11), 1128-1133, 2016 | 39 | 2016 |
| Liraglutide as add‐on to sodium‐glucose co‐transporter‐2 inhibitors in patients with inadequately controlled type 2 diabetes: LIRA‐ADD2SGLT2i, a 26‐week, randomized, double … L Blonde, L Belousova, U Fainberg, PA Garcia‐Hernandez, SM Jain, ... Diabetes, Obesity and Metabolism 22 (6), 929-937, 2020 | 36 | 2020 |
| Bone metabolism and osteoporosis during pregnancy and lactation AY Lujano-Negrete, MC Rodríguez-Ruiz, CM Skinner-Taylor, ... Archives of Osteoporosis 17 (1), 36, 2022 | 23 | 2022 |
| Consenso de diagnóstico y tratamiento de la osteoporosis en la mujer posmenopáusica mexicana. DH Peña-Ríos, FA Cisneros-Dreinhofer, PA García-Hernández, ... Medicina Interna de Mexico 31 (5), 2015 | 21 | 2015 |
| Insulin degludec/liraglutide (IDegLira) is superior to insulin glargine (IG) in A1C reduction, risk of hypoglycemia, and weight change: Dual V study JB Buse, FC Perez Manghi, PA Garcia-Hernandez, P Norwood, ... Diabetes 64, A43-A44, 2015 | 16 | 2015 |
| Intermittent intravenous ibandronate injections are an effective treatment option in postmenopausal osteoporosis: 2-year results from DIVA JA Eisman, PA Garcia-Hernandez, G Ortiz-Luna, LG Ste-Marie, C Hughes, ... OSTEOPOROSIS INTERNATIONAL 17, S212-S212, 2006 | 15 | 2006 |
| Value of body mass index in the diagnosis of obesity according to DEXA in well-controlled RA patients N Tello-Winniczuk, D Vega-Morales, PA García-Hernandez, ... Reumatología Clínica (English Edition) 13 (1), 17-20, 2017 | 14 | 2017 |
| Significantly Better Glycemic Control and Weight Reduction with Liraglutide, a Once-Daily Human GLP-1 Analog, Compared With Glimepiride: All as Monotherapy In Type 2 Diabetes. A Garber, R Henry, R Ratner, P Garcia-Hernandez, HMR Pattzi, ... Canadian Journal of Diabetes 32 (4), 328, 2008 | 14 | 2008 |
| Metabolomics of the diabetic nephropathy: behind the fingerprint of development and progression indicators P Cordero-Pérez, C Sánchez-Martínez, PA García-Hernández, ... Nefrología (English Edition) 40 (6), 585-596, 2020 | 12 | 2020 |
| Deficiencia de vitamina D en madres y neonatos mexicanos EC Ochoa Correa, PA García Hernández, JZ Villarreal Pérez, ... Gaceta médica de México 153 (5), 559-565, 2017 | 11 | 2017 |
